Previsioni di mercato per il trattamento della sarcopenia in Medio Oriente e Africa fino al 2030 - Analisi regionale - per tipo di trattamento (integratore di vitamina D e calcio, integratore proteico, integratore di vitamina B12 e altri) e canale di distribuzione (farmacie, canali di vendita al dettaglio, canali online e altri)
La crescente consapevolezza sulla sarcopenia rafforza il mercato del trattamento della sarcopenia in Medio Oriente e Africa
La crescente consapevolezza della sarcopenia e il suo impatto negativo sulla salute presenta un ambito significativo per i progressi nei settori dell’assistenza sanitaria e dell’assistenza geriatrica. Molti gruppi e organizzazioni di difesa stanno adottando misure proattive per aumentare la consapevolezza della sarcopenia tra le masse. Queste organizzazioni spesso lavorano con professionisti medici per mantenere il pubblico aggiornato sui vari aspetti di alcuni disturbi, come la patogenicità, i pazienti target, la prevenzione e i trattamenti, oltre a sottolineare il valore di una diagnosi e di un trattamento tempestivi. In linea con la campagna “Stronger than Sarcopenia” di OWH, le donne sono invitate a discutere della sarcopenia con i loro operatori sanitari, per poi sottoporsi a uno screening per la malattia e assumere una terapia adeguata, se necessario.
Sarcopenia è stata inclusa nei programmi di studio delle scuole di medicina e nei programmi di formazione per operatori sanitari come medici, infermieri e fisioterapisti. Ad esempio, l’OWH ha collaborato con Medscape Education per creare crediti di formazione medica continua (ECM) per gli operatori sanitari, che li attrezzeranno meglio per individuare e curare la sarcopenia nei loro pazienti. I media mainstream hanno ampliato la loro copertura sulla sarcopenia includendo articoli, notizie e documentari. Pertanto, la crescente consapevolezza riguardo alla sarcopenia porterà probabilmente nuove tendenze di crescita nel mercato del trattamento della sarcopenia nei prossimi anni.
Panoramica del mercato del trattamento della sarcopenia in Medio Oriente e Africa
Il mercato del trattamento della sarcopenia in Medio Oriente e Africa è segmentato in Arabia Saudita, Emirati Arabi Uniti, Sud Africa e resto del MEA. Gli Emirati Arabi Uniti e l\'Arabia Saudita sono tra i contributori più significativi al mercato a causa della crescente incidenza di disturbi ortopedici. Anche una maggiore consapevolezza tra la grande popolazione sull’uso e sui benefici degli integratori alimentari va a vantaggio del progresso del mercato.
Un aumento del rischio di sarcopenia in Sud Africa è associato all\'invecchiamento della popolazione e all\'inadeguata sicurezza alimentare e all\'assunzione di nutrienti causati dalla povertà. Si prevede che il mercato del trattamento della sarcopenia in questo paese sarà guidato da un distinto approccio specifico per la popolazione adottato dalle autorità sanitarie per la diagnosi, il trattamento e la prevenzione della sarcopenia.
Previsioni e entrate del mercato del trattamento della sarcopenia in Medio Oriente e Africa fino al 2030 (milioni di dollari)
Segmentazione del mercato del trattamento della sarcopenia in Medio Oriente e Africa
Trattamento della sarcopenia in Medio Oriente e Africa il mercato è classificato in tipo di trattamento, canale di distribuzione e paese.
In base al tipo di trattamento, il mercato del trattamento della sarcopenia in Medio Oriente e Africa è segmentato in integratore di vitamina D e calcio, integratore proteico, integratore di vitamina B12 e altri. Il segmento degli integratori di vitamina D e calcio ha detenuto la maggiore quota di mercato del trattamento della sarcopenia in Medio Oriente e Africa nel 2022.
In termini di canale di distribuzione, il mercato del trattamento della sarcopenia in Medio Oriente e Africa è segmentato in farmacie, canali di vendita al dettaglio, online canali e altri. Il segmento delle farmacie ha detenuto la maggiore quota di mercato del trattamento della sarcopenia in Medio Oriente e Africa nel 2022.
Per paese, il mercato del trattamento della sarcopenia in Medio Oriente e Africa è segmentato in Arabia Saudita, Sud Africa, Emirati Arabi Uniti e resto del mondo. Medio Oriente e Africa. Il Sud Africa ha dominato la quota di mercato del trattamento della sarcopenia in Medio Oriente e Africa nel 2022.
Abbott Laboratories, Bayer AG, Nestlé Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp e GSK Plc sono alcuni dei le aziende leader che operano nel mercato del trattamento della sarcopenia in Medio Oriente e Africa.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Middle East & Africa Sarcopenia Treatment Market Forecast and Analysis
6. Middle East & Africa Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Sarcopenia Treatment Market - Country Analysis
8.1 Middle East & Africa
8.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 Rest of Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Nestle Health Science SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novartis AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Pfizer Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Sanofi SA
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Amway Corp
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 GSK Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Country
Table 7. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 8. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 9. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 10. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 11. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 12. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 13. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 14. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 15. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 16. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 17. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Middle East & Africa Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Middle East & Africa Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Middle East & Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
Figure 17. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
Figure 18. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Nestle Health Science SA
4. Novartis AG
5. Pfizer Inc
6. Sanofi SA
7. Amway Corp
8. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.